Just a sample of the Echomail archive
Cooperative anarchy at its finest, still active today. Darkrealms is the Zone 1 Hub.
|    EARTH    |    Uhh, that 3rd rock from the sun?    |    8,931 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 8,350 of 8,931    |
|    ScienceDaily to All    |
|    Protein-based nano-'computer' evolves in    |
|    26 May 23 22:30:26    |
      MSGID: 1:317/3 64718770       PID: hpt/lnx 1.9.0-cur 2019-01-08       TID: hpt/lnx 1.9.0-cur 2019-01-08        Protein-based nano-'computer' evolves in ability to influence cell       behavior                Date:        May 26, 2023        Source:        Penn State        Summary:        The first protein-based nano-computing agent that functions as a        circuit has been created. The milestone puts them one step closer        to developing next-generation cell-based therapies to treat diseases        like diabetes and cancer.                      Facebook Twitter Pinterest LinkedIN Email              ==========================================================================       FULL STORY       ==========================================================================       The first protein-based nano-computing agent that functions as a circuit       has been created by Penn State researchers. The milestone puts them one       step closer to developing next-generation cell-based therapies to treat       diseases like diabetes and cancer.              Traditional synthetic biology approaches for cell-based therapies, such       as ones that destroy cancer cells or encourage tissue regeneration after       injury, rely on the expression or suppression of proteins that produce a       desired action within a cell. This approach can take time (for proteins       to be expressed and degrade) and cost cellular energy in the process. A       team of Penn State College of Medicine and Huck Institutes of the Life       Sciences researchers are taking a different approach.              "We're engineering proteins that directly produce a desired action,"       said Nikolay Dokholyan, G. Thomas Passananti Professor and vice chair       for research in the Department of Pharmacology. "Our protein-based       devices or nano-computing agents respond directly to stimuli (inputs)       and then produce a desired action (outputs)." In a study published in       Science Advances today (May 26) Dokholyan and bioinformatics and genomics       doctoral student Jiaxing Chen describe their approach to creating their       nano-computing agent. They engineered a target protein by integrating       two sensor domains, or areas that respond to stimuli. In this case,       the target protein responds to light and a drug called rapamycin by       adjusting its orientation, or position in space.              To test their design, the team introduced their engineered protein into       live cells in culture. By exposing the cultured cells to the stimuli,       they used equipment to measure changes in cellular orientation after       cells were exposed to the sensor domains' stimuli.              Previously, their nano-computing agent required two inputs to produce       one output. Now, Chen says there are two possible outputs and the       output depends on which order the inputs are received. If rapamycin is       detected first, followed by light, the cell will adopt one angle of cell       orientation, but if the stimuli are received in a reverse order, then the       cell adopts a different orientation angle. Chen says this experimental       proof-of-concept opens the door for the development of more complex       nano-computing agents.              "Theoretically, the more inputs you embed into a nano-computing agent, the       more potential outcomes that could result from different combinations,"       Chen said.              "Potential inputs could include physical or chemical stimuli and outputs       could include changes in cellular behaviors, such as cell direction,       migration, modifying gene expression and immune cell cytotoxicity       against cancer cells." The team plans to further develop their       nano-computing agents and experiment with different applications of the       technology. Dokholyan, a researcher with Penn State Cancer Institute       and Penn State Neuroscience Institute, said their concept could someday       form the basis of the next-generation cell-based therapies for various       diseases, such as autoimmune diseases, viral infections, diabetes,       nerve injury and cancer.              Yashavantha Vishweshwaraiah, Richard Mailman and Erdem Tabdanov of Penn       State College of Medicine also contributed to this research. The authors       declare no conflicts of interest.              This work was funded by the National Institutes of Health (grant       1R35GM134864) and the Passan Foundation.               * RELATED_TOPICS        o Health_&_Medicine        # Stem_Cells # Lung_Cancer # Lymphoma        o Plants_&_Animals        # Cell_Biology # Molecular_Biology #        Biotechnology_and_Bioengineering        o Matter_&_Energy        # Biochemistry # Batteries # Organic_Chemistry        o Computers_&_Math        # Computer_Science # Mobile_Computing #        Spintronics_Research        * RELATED_TERMS        o Blood_transfusion o Stem_cell_treatments o Stem_cell o        Chemotherapy o Gene_therapy o Nutrition o Personalized_medicine        o Circuit_design              ==========================================================================       Story Source: Materials provided by Penn_State. Original written by       Zachary Sweger. Note: Content may be edited for style and length.                     ==========================================================================       Journal Reference:        1. Jiaxing Chen, Yashavantha L. Vishweshwaraiah, Richard B. Mailman,        Erdem        D. Tabdanov, Nikolay V. Dokholyan. A noncommutative        combinatorial protein logic circuit controls cell orientation        in nanoenvironments. Science Advances, 2023; 9 (21) DOI:        10.1126/sciadv.adg1062       ==========================================================================              Link to news story:       https://www.sciencedaily.com/releases/2023/05/230526142234.htm              --- up 1 year, 12 weeks, 4 days, 10 hours, 50 minutes        * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)       SEEN-BY: 15/0 106/201 114/705 123/120 153/7715 218/700 226/30 227/114       SEEN-BY: 229/110 112 113 307 317 400 426 428 470 664 700 291/111 292/854       SEEN-BY: 298/25 305/3 317/3 320/219 396/45       PATH: 317/3 229/426           |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca